Hematology Oncology market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity.
The global Hematology Oncology market size was estimated at USD 4.30 billion in 2023 and is projected to reach USD 11.04 billion in 2030 at a CAGR of 14.41% during the forecast period 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/hematology-oncology-market
Hematology oncology is a medical specialty that focuses on the diagnosis, treatment, and management of blood disorders (hematology) and cancer (oncology). Hematology oncologists are trained to handle conditions such as leukemia, lymphoma, multiple myeloma, and other blood related cancers, as well as solid tumors. They use a combination of chemotherapy, radiation therapy, targeted therapy, immunotherapy, and other advanced treatments to provide comprehensive care to patients with these conditions.
The hematology oncology market is expected to grow during the forecast period. This growth can be attributed to the rise in the prevalence of lymphoma and myeloma, rise in the healthcare infrastructure and rise in the geriatric population all over the world. Moreover, the availability of more sophisticated molecular techniques for the diagnosis of hemato oncology has also increased. In addition, increased demand for laboratory automation, and more awareness of preventative healthcare are expected to drive the market during the forecast period.
Regional Analysis
North America to Dominate the Market
• North America is estimated to account for the largest market share during the forecast period. This growth can be attributed to the rise in incidence of leukemia, lymphoma, and multiple myeloma within the region.
• Moreover, the strong presence of the key players in the region is driving the growth of the market further.
Competitive Landscape
• Agilent Technologies Inc.
• Beijing Genomics Institute
• Caris Life Sciences
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Foundation Medicine Inc.
• Illumina, Inc.
• Myriad Genetics Inc.
• Oxford Nanopore Technologies plc.
• PacBio
• Paradigm Diagnostics Inc.
• Partek Incorporated
• Perkin Elmer Inc.
• Qiagen
• Thermo Fisher Scientific Inc. and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/hematology-oncology-market
Recent Developments
In June 2022, Thermo Fisher Scientific Inc. expanded its extensive line of automated connective tissue disease tests by releasing the new EliA RNA Pol III and EliA Rib-P blood tests to assist in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus (SLE).
In 2022, F. Hoffman-La Roche Ltd. Received FDA approval for the cobras EZH2 mutation test as a companion diagnostic for patients with follicular lymphoma.
The Hematology Oncology Market is segmented into various segments such as product, drug class type, oncology indication, end users, and region:
Based on Product
• Hematology Analyzers
• Hematology Reagents
• Flow Cytometers
• Hematology Cell Counters
• Slide Strainers
• Coagulation Analyzers
• Hematology Testing
• Centrifuges
• Hemoglobin meters
• Others
Based on Drug Class Type
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
Based on Oncology Indication
• Lung Cancer
• Stomach Cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Liver Cancer
• Esophagus Cancer
• Cervical Cancer
• Kidney Cancer
• Bladder Cancer
• Others
Based on End Users
• Hospitals
• Clinical Testing Institutes
• Patient Self-Testing
• Other End-Users
The Report helps to identify the opportunities in Global Regions:
• North America (the United States, Canada, and Mexico)
• Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
• South America (Brazil etc.)
• The Middle East and Africa (North Africa and GCC Countries)
Access Full Report: https://www.delvens.com/report/hematology-oncology-market
In addition to the market data for the Hematology Oncology Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
More Reports From Delvens:
Multiple Sclerosis (MS) market size was estimated at USD 25.2 billion in 2023 and is projected to reach USD 34.9 billion in 2030 at a CAGR of 4.76% during the forecast period 2023-2030.
Plastic Surgery and Integumentary System Market size was estimated at USD 3.02 billion in 2023 and is projected to reach USD 4.3 billion in 2030 at a CAGR of 5.2% during the forecast period 2023-2030.
Pain Relief Gel market size was estimated at USD 10.4 billion in 2023 and is projected to reach USD 15.3 billion in 2030 at a CAGR of 5.2% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
[email protected]